Main Newsletter
Mastery Series
Therapy Series
Letter From The Editor

The diabetes drug arena is getting more crowded by the day as new classes of drugs like SGLT-2 inhibitors and GLP-1 analogs seem to be getting approved at a quick pace. In addition there are classes of drugs that are in phase 2 and 3 trials that we have yet to think or hear about. We are even hearing about drugs tailored to work for patients with a specific genetic variation.

But for all these new care solutions that we have, there is a problem that keeps our patients from getting to their goals and that problem is Medication Adherence.

According to a working group assembled by the NACDS Foundation, the Pharmacy Quality Alliance, and NEHI, the U.S. health care system must address the problem of patients not picking up newly prescribed medicines if national goals for improved health and reduced costs of medical care will be realized. According to information in Ready for Pick Up: Reducing Primary Medication Non-Adherence -- A New Prescription for Health Care Improvement, a white paper issued by the Network for Excellence in Health Innovation (NEHI), if we don’t find a way to reduce the problem of prescriptions for newly initiated therapy that are not picked up for the first time and thus never taken, we will never reach health care goals and this will likely lead to worse patient health and increased stress on the healthcare system. This information parallels another study that indicates that most patients are taking their diabetes medications less that 60% of the prescribed times per day and often discontinue all medication therapy within 9 years of diagnosis.

To help ensure that your patients start on their medications, I urge you to add a note to your electronic prescribing system asking the pharmacist to notify you if the patient does not pick up their prescription. 


With a day packed full of education, motivational tools, one-on-one sessions, and workshops, the TCOYD health fair is a great way to get your patients to take better care of their health and themselves. 
From "Joy Pape RN, CDE answers your diabetes questions from the dLife mail; Chef Michel Nischan shows us a modern take on another Italian classic - chicken saltimbocca; Jim Turner and friends talk about diabetes and cravings." Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at
We can make a difference!

Dave Joffe, Editor-in-chiefRead More

Scroll down for items in the current newsletter


Trulicity One-Weekly GLP-1 Shipping Now 

Eli Lilly and Company announced that Trulicity, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) with once-weekly dosing in the Trulicity pen, was approved by the FDA on September 18, 2014, and is shipping to distributors now.

Tool for your Practice

Updated: Comprehensive List of Insulins 

comprehensive-insulin-tool-imageThis comprehensive and up-to-date list is a printable pdf which includes Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, and Pre-Mixed or Combination Insulins. Detailed information on these insulins includes: Indications, Pharmacology, Dosage and Administration, Adverse Effects, and Precautions and Contraindications. To download this 27-page PDF, just follow this link: Comprehensive List of Insulins

Product of the Week

Garmin Vivofit 

The Heart Rate Watch Company rated this the best of show for CES 2014. Unlike bands that have to be recharged every few days, it uses a coin battery that should last a year. It tracks inactivity with a red bar that grows as you sit to remind you to get up and get moving. It tracks steps, distance, calories, and sleep. You can link it with a heart rate monitor. Track your fitness online on the Garmin Connect site and Bluetooth Smart mobile apps.


Mobile App of the Week

PubMed Unbound Medline


Unbound MEDLINE connects you to over 20 million journal citations and abstracts from PubMed via your smartphone. Perform powerful searches and link to the publisher's full text articles. Visually explore the literature using Grapherence, a unique way to find related and relevant articles. To find out more and download the app, just follow this link.






Test Your Knowledge Question

All of the following drugs can affect blood glucose levels except:

a)    Digoxin
b)    Ranitidine
c)    Metformin
d)    Triamterene

For the complete question and answer, just follow this link.


Diabetes In Control Has Over 15000 Studies & Articles In Our Archives

Quote of the Week!

“Put your heart, mind, and soul into even your smallest acts. This is the secret of success.”
                                                                                                    ...Swami Sivananda


Diabetes in Control gratefully acknowledges the assistance of the following University of Florida pharmacy doctoral candidate in the preparation of this week's newsletter: 

Arpita Patel, LECOM University 

Paul Dreabit, LECOM University

LanAhn Doan, Florida A&M University



Cast Your Vote
Are your patients getting enough glucose strips to manage their diabetes?


Search Articles On Diabetes In Control